BR0117054A - Formas cristalinas do ácido 4-[4-[4-hidroxidifenilmetil)-1-piperidinil]-1-hidroxibuti l]-alfa, alfa-dimetilbenzeno acético e seu cloridrato - Google Patents

Formas cristalinas do ácido 4-[4-[4-hidroxidifenilmetil)-1-piperidinil]-1-hidroxibuti l]-alfa, alfa-dimetilbenzeno acético e seu cloridrato

Info

Publication number
BR0117054A
BR0117054A BR0117054-6A BR0117054A BR0117054A BR 0117054 A BR0117054 A BR 0117054A BR 0117054 A BR0117054 A BR 0117054A BR 0117054 A BR0117054 A BR 0117054A
Authority
BR
Brazil
Prior art keywords
alpha
hydrochloride
hydroxydiphenylmethyl
hydroxybutyl
piperidinyl
Prior art date
Application number
BR0117054-6A
Other languages
English (en)
Inventor
M Satyanarayana Reddy
S Thirumalai Rajan
U V Bhaskara Rao
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of BR0117054A publication Critical patent/BR0117054A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"FORMAS CRISTALINAS DO áCIDO 4-[4-[4-HIDROXIDIFENILMETIL)-1-PIPERIDINIL]-1-HIDROXIBUTI L]-ALFA,ALFA-DIMETIL-BENZENO ACéTICO E SEU CLORIDRATO". A presente invenção refere-se a novas formas polimorfas de Fexofenadina e de cloridrato de Fexofenadina de fórmula 1 e a processo de preparação das mesmas. A presente invenção também é direcionada para proporcionar novas formas polimorfas puras de Fexofenadina e de seu cloridrato por um processo simples que é custo efetivo, comercialmente viável e ambientalmente conveniente.
BR0117054-6A 2001-06-18 2001-07-31 Formas cristalinas do ácido 4-[4-[4-hidroxidifenilmetil)-1-piperidinil]-1-hidroxibuti l]-alfa, alfa-dimetilbenzeno acético e seu cloridrato BR0117054A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN484MA2001 2001-06-18
PCT/US2001/023994 WO2002102777A2 (en) 2001-06-18 2001-07-31 NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE

Publications (1)

Publication Number Publication Date
BR0117054A true BR0117054A (pt) 2004-07-27

Family

ID=34566868

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0117054-6A BR0117054A (pt) 2001-06-18 2001-07-31 Formas cristalinas do ácido 4-[4-[4-hidroxidifenilmetil)-1-piperidinil]-1-hidroxibuti l]-alfa, alfa-dimetilbenzeno acético e seu cloridrato

Country Status (20)

Country Link
EP (2) EP2261209A1 (pt)
JP (2) JP2005507374A (pt)
KR (1) KR20040015734A (pt)
CN (1) CN100390145C (pt)
AU (1) AU2001278094B2 (pt)
BG (1) BG108435A (pt)
BR (1) BR0117054A (pt)
CA (2) CA2450858C (pt)
CO (1) CO5540340A2 (pt)
CZ (1) CZ20033358A3 (pt)
EE (1) EE200400010A (pt)
HU (1) HUP0401546A2 (pt)
IL (2) IL159266A0 (pt)
MX (1) MXPA03011728A (pt)
NZ (1) NZ530118A (pt)
PL (1) PL367632A1 (pt)
RU (1) RU2269516C2 (pt)
SK (1) SK15372003A3 (pt)
WO (1) WO2002102777A2 (pt)
ZA (1) ZA200309557B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366576A1 (en) * 2001-04-09 2005-02-07 Teva Pharmaceutical Industries Ltd. Polymorphs of fexofenadine hydrochloride
ES2239554T1 (es) 2002-06-10 2005-10-01 Teva Pharmaceutical Industries Ltd. Forma xvi polimorfica de hidrocloruro de fexofenadina.
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
CA2560882A1 (en) * 2004-04-26 2005-11-03 Teva Pharmaceutical Industries Ltd. Crystalline forms of fexofenadine hydrochloride and processes for their preparation
ITMI20041143A1 (it) * 2004-06-08 2004-09-08 Dipharma Spa Polimorfi di fexofenadina e procedimento per la loro preparazione
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
WO2006037042A1 (en) * 2004-09-28 2006-04-06 Teva Pharmaceutical Industries Ltd. Fexofenadine crystal form and processes for its preparation thereof
WO2007007347A1 (en) * 2005-07-07 2007-01-18 Wockhardt Limited Industrial process of fexofenadine hydrochloride with controlled side products
US20090306135A1 (en) 2008-03-24 2009-12-10 Mukesh Kumar Sharma Stable amorphous fexofenadine hydrochloride
CN104072402B (zh) * 2014-07-16 2016-08-17 昆山龙灯瑞迪制药有限公司 一种新结晶形式的盐酸非索非那定化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
CN1148849A (zh) * 1994-05-18 1997-04-30 赫彻斯特马里恩鲁斯公司 抗组胺哌啶衍生物,其多晶形物和假同晶物的无水和水合物形式的制备方法
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
IN191492B (pt) 1999-05-25 2003-12-06 Ranbaxy Lab Ltd
GB0018691D0 (en) * 2000-07-28 2000-09-20 Rolabo Sl Process

Also Published As

Publication number Publication date
JP2008094848A (ja) 2008-04-24
HUP0401546A2 (hu) 2004-12-28
WO2002102777A3 (en) 2003-02-27
WO2002102777A2 (en) 2002-12-27
KR20040015734A (ko) 2004-02-19
RU2004101045A (ru) 2005-06-27
WO2002102777A8 (en) 2003-10-30
PL367632A1 (en) 2005-03-07
CA2450858A1 (en) 2002-12-27
CN100390145C (zh) 2008-05-28
RU2269516C2 (ru) 2006-02-10
CA2450858C (en) 2009-04-07
EE200400010A (et) 2004-02-16
NZ530118A (en) 2007-05-31
ZA200309557B (en) 2004-09-14
AU2001278094B2 (en) 2006-01-12
CA2646802A1 (en) 2002-12-27
EP2261209A1 (en) 2010-12-15
SK15372003A3 (sk) 2004-08-03
IL159266A (en) 2010-11-30
EP1399422A2 (en) 2004-03-24
IL159266A0 (en) 2004-06-01
CO5540340A2 (es) 2005-07-29
MXPA03011728A (es) 2004-07-08
CN1518540A (zh) 2004-08-04
JP2005507374A (ja) 2005-03-17
BG108435A (en) 2004-12-30
CZ20033358A3 (en) 2004-04-14

Similar Documents

Publication Publication Date Title
BR0117054A (pt) Formas cristalinas do ácido 4-[4-[4-hidroxidifenilmetil)-1-piperidinil]-1-hidroxibuti l]-alfa, alfa-dimetilbenzeno acético e seu cloridrato
US20050153963A1 (en) N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
BRPI0812625A2 (pt) processo para preparar um sal de cis-atracúrio
SE0103046D0 (sv) Kristallin bas av citalopram
DK0444563T3 (da) 3-Hydroxy-2-cyclobuten-1-on-salte, deres fremstilling og anvendelse
BR0213931A (pt) Forma polimórfica de rimonabant, processo para sua preparação e composições farmacêuticas contendo-as
BRPI0500585B8 (pt) processo para a síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
CA2393559A1 (en) Methods for the syntheses of alfentanil, sufentanil and remifentanil
EA200801518A1 (ru) Новый способ получения высокочистого полиморфа (i) донепезила гидрохлорида
WO2006015338A3 (en) Crystalline form of donepezil hydrochloride
JP2007507443A5 (pt)
ES2275066T3 (es) Procedimiento para la preparacion de donepezilo.
WO1995031436A1 (en) PROCESS AND DIASTEREOMERIC SALTS USEFUL FOR THE OPTICAL RESOLUTION OF RACEMIC α-[4-(1,1-DIMETHYLETHYL)PHENYL]-4-(HYDROXYDIPHENYLMETHYL)-1-PIPERIDINEBUTANOL AND DERIVATIVE COMPOUNDS
HU178532B (en) Process for producing 1,2,4,5-tetraalkyl-4-aryl-piperidine derivatives
DE60303167D1 (de) Verfahren zur Herstellung von Glycidylphthalimid
TW200637856A (en) Process for producing thiazolidinedion compound and intermediate thereof
US2819305A (en) Aminoalkylamides of butoxybenzoic acid
DE60203142D1 (de) Verfahren zur Herstellung von 4-[1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)-butyl]-alpha, alpha-dimethylphenylessigsäure
AR038342A1 (es) Derivados piridin-amido
NO20053176L (no) Fremgangsmate for fremstilling av tolperisonsalter.
NO20032314D0 (no) Nye desloratadinsalter, fremgangsmåte for deres syntese og farmasöytiske preparater derav
ATE455088T1 (de) Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
BRPI0409012A (pt) processos para preparação de um produto reacional, de uma composição farmacêutica, de uma composição agroquìmica, de uma composição de limpeza, de uma composição de tinta e de um refrigerante ou lubrificante
JP2005206610A5 (pt)
AR036881A1 (es) Un proceso para la preparacion de 4-(piperidil)(2-piridil)metanona-(e)-o-metiloxima y sales

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.